CIK 0001649904
- Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462159271
- Phone
- +1 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,753,355
- in 2 filings, $11.8M under 10b5-1 plans
Net −$11,753,355. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-01 | Lee Jennifer Kayden EVP, Head of North America | Sale | −1,492 | $45.06 | $67K | 3,021 |
| 2024-02-01 | Lee Jennifer Kayden EVP, Head of North America | Option exercise · Restricted Stock Units | −4,513 | 13,537 | ||
| 2024-02-01 | Smith Hunter C Chief Financial Officer | Option exercise | +4,925 | 76,831 | ||
| 2024-02-01 | Smith Hunter C Chief Financial Officer | Sale | −1,616 | $45.06 | $73K | 75,215 |
| 2024-02-01 | Smith Hunter C Chief Financial Officer | Option exercise · Restricted Stock Units | −4,925 | 14,775 | ||
| 2024-02-01 | Shulman Joseph Chief Technical Officer | Option exercise | +3,938 | 3,938 | ||
| 2024-02-01 | Shulman Joseph Chief Technical Officer | Sale | −1,324 | $45.06 | $60K | 2,614 |
| 2024-02-01 | Shulman Joseph Chief Technical Officer | Option exercise · Restricted Stock Units | −3,938 | 11,812 | ||
| 2024-02-01 | Meeker David P President and CEO | Option exercise | +14,125 | 125,460 | ||
| 2024-02-01 | Meeker David P President and CEO | Sale | −4,361 | $45.06 | $197K | 121,099 |
| 2024-02-01 | Meeker David P President and CEO | Option exercise · Restricted Stock Units | −14,125 | 42,375 | ||
| 2024-02-01 | Cramer Pamela J. Chief Human Resources Officer | Option exercise | +2,650 | 11,068 | ||
| 2024-02-01 | Cramer Pamela J. Chief Human Resources Officer | Sale | −946 | $45.06 | $43K | 10,122 |
| 2024-02-01 | Cramer Pamela J. Chief Human Resources Officer | Option exercise · Restricted Stock Units | −2,650 | 7,950 | ||
| 2023-12-29 | Smith Hunter C Chief Financial Officer | Option exercise | +10,500 | $6.88 | $72K | 71,906 |
| 2023-12-29 | Smith Hunter C Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −10,500 | 100,594 | ||
| 2023-12-28 | Shulman Joseph Chief Technical Officer | Option exercise 10b5-1 | +6,800 | $21.38 | $145K | 7,926 |
| 2023-12-28 | Shulman Joseph Chief Technical Officer | Sale 10b5-1 | −7,926 | $50.00 | $396K | 0 |
| 2023-12-28 | Shulman Joseph Chief Technical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,800 | 75,800 | ||
| 2023-12-27 | Shulman Joseph Chief Technical Officer | Option exercise 10b5-1 | +2,400 | $21.38 | $51K | 6,141 |
Page 31 of 36 · 701 trades